VistaGen Therapeutics (VTGN) Stock Highlights

2.5 | +11.11%

2024-12-21 06:58:27

VistaGen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of a major depressive disorder in patients with an inadequate response to standard antidepressants. The PH94B is a novel neuroactive nasal spray with therapeutic potential in a wide range of indications involving anxiety or phobia; PH10 is an odorless, fast-acting synthetic neurosteroid for neuropsychiatric indications involving depression.

Statistics

Range Today

2.23 2.55

Volume Today 990.2K

Range 1 Year

2.22 5.86

Volume 1 Year 51.5M

Range 3 Year

1.62 63.3

Volume 3 Year 284.23M

Range 10 Year

1.62 495

Volume 10 Year 326.05M

Highlights

Market Capitalization 84.95M (small)

Floating Shares 15.84M

Current Price 2.5

Price To Earnings -3.33

Price To Revenue -22.62

Price To Book 0.74

Earnings Per Share -0.94

Payout Ratio 0%

Performance

Latest +11.11%

1 Month -6.37%

3 Months -17.49%

6 Months -24.92%

1 Year -53.18%

3 Years -95.42%

5 Years -89.71%

10 Years -99.02%

Benchmarks

Market Capitalization

243 / 368

Gross Profits

153 / 278

Total Revenue

241 / 300

Total Rank

366 / 368

Free Cashflow

141 / 352

Performance 5 years

263 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.